Keywords: alpharma, 2nd, qtr, sees, revenue, rise, usa-based
Alpharma's 2nd qtr sees 16% revenue rise
Article | 15 August 2005
Alpharma, a USA-based branded and generic drugmaker, has reported that its diluted earnings per share for second-quarter 2005 soared 123% to $0.38 due ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Athera and Boehringer Ingelheim enter option agreement on a novel therapy for atherosclerosis
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Australia's pharma industry applauds R&D regulatory reform
